Breaking News

Quay Opens Packing and Distribution Facility

March 19, 2013

Will support clinical trials from Deeside headquarters

Quay Pharma is expanding its services to support clinical trials with the establishment of a dedicated packing and distribution facility at its Deeside headquarters. The new MHRA-approved area allows Quay to provide both bulk delivery of product and to meet increasing demands for just-in-time deliveries to support randomized and blinded studies.
 
Quay offers the filling of primary packs including bottles, tubes, blister packs, sachets and oral dosing syringes, followed by secondary packing. The company offers multi-language labeling, blinding and randomization and, though its sister company, Chester Medical, can provide individually designed patient packs. Quay also supports cold chain management, including shipping and storage. The inclusion of tamper-evident seals and code break labels can be incorporated as part of the packing process.
 
“Quay has developed this service to assist a number of our clients for whom we have developed products, as they move through to Phase II and Phase III clinical trials,” said Quay Pharma chief executive Maireadh Pedersen. “This is an important enhancement to our client offering, enabling us to continue to support our customers throughout their development phase.”

Related Contract Manufacturing:

Related Packaging:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research